A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis
暂无分享,去创建一个
A Forbes | K Ray Chaudhuri | D J Burn | A. Forbes | D. Burn | K. Chaudhuri | L. Findley | R. Walker | G. Carey | M. Baker | D. Grosset | N. Qizilbash | C. Clough | A. Bowron | S. Smith | D. Macmahon | N Qizilbash | U. Brechany | D. Grosset | L. Taurah | K. Turner | O. Foster | K. Patel | C. Clough | B. Castleton | G. Carey | T. Murphy | J. Hill | P. McGee | S. Reading | G. Brand | L. Kelly | K. Breen | S. Ford | A. Williams | J. Hearne | D Grosset | L Taurah | D MacMahon | K Turner | A Bowron | R Walker | L Findley | O Foster | K Patel | C Clough | B Castleton | S Smith | G Carey | T Murphy | J Hill | U Brechany | P McGee | S Reading | G Brand | L Kelly | K Breen | S Ford | M Baker | A Williams | J Hearne | Jessica A. Hill | D. MacMahon | Ls Taurah | Simon Smith | P. Mcgee | Linda Kelly | Una Brechany
[1] E. Lai,et al. Non-motor Symptoms of Parkinson's Disease , 2007 .
[2] Paolo Barone,et al. International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[3] N. MacLusky,et al. Neurologic links between epilepsy and depression in women , 2006, Neurology.
[4] Kallol Ray Chaudhuri,et al. International validation of the first united non motor symptoms scale for Parkinson's disease. Results from the first pilot NMSS study , 2006 .
[5] J. Obeso,et al. Timing of treatment initiation in Parkinson's disease: A need for reappraisal? , 2006, Annals of neurology.
[6] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[7] M. Aminoff. Treatment should not be initiated too soon in Parkinson's disease , 2006, Annals of neurology.
[8] John Seibyl,et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. , 2004, Archives of neurology.
[9] E. Montgomery,et al. Slowing Parkinson’s disease progression: Recent dopamine agonist trials , 2004, Neurology.
[10] The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.
[11] Michael P McDermott,et al. Development and testing of the Parkinson's disease quality of life scale , 2003, Movement disorders : official journal of the Movement Disorder Society.
[12] J. Jankovic,et al. Slowing Parkinson’s disease progression , 2003, Neurology.
[13] A. Lang,et al. Measuring motor complications in clinical trials for early Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[14] M. Guttman,et al. Dopamine agonist monotherapy in Parkinson's disease , 2002, The Lancet.
[15] S. Frucht,et al. An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines , 2002, Neurology.
[16] R. Fitzpatrick,et al. Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. , 2001, Age and ageing.
[17] R M Werner,et al. The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[18] W. Stewart,et al. Headache-related disability in the management of migraine , 2001, Neurology.
[19] John Seibyl,et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. , 2000, JAMA.
[20] L. Findley,et al. Quality of life in Parkinson's disease , 1999, International journal of clinical practice.
[21] W. Koller,et al. An algorithm (decision tree) for the management of Parkinson's disease , 1998, Neurology.
[22] R. Fitzpatrick,et al. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. , 1997, Age and ageing.
[23] R. Fitzpatrick,et al. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) , 1995, Age and ageing.
[24] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[25] S. Leurgans,et al. Addressing non-motor impairments in Parkinson's disease: The new version of the UPDRS , 2005 .
[26] Fabrizio Stocchi,et al. Factors impacting on quality of life in Parkinson's disease: Results from an international survey , 2002, Movement disorders : official journal of the Movement Disorder Society.
[27] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[28] H. Fukunaga,et al. Clinical findings, status of care, comprehensive quality of life, daily life therapy and treatment at home in patients with Parkinson's disease. , 1997, European neurology.
[29] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[30] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .